Reuters
25 Sept 2026, 20:38 UTC · 2h ago
Verdict
Headline takes no side. We score 4568 −0.60 across one claim — strongly bearish.
−0.60strongly bearish
More negative than 78% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Merck and Daiichi Sankyo have voluntarily withdrawn their US application for accelerated approval of an experimental lung cancer therapy.
Newsaid on Friday
More negative than 95% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 78% of ticker scores this week
The company voluntarily withdrew its US application for accelerated approval of an experimental lung cancer therapy.
More negative than 78% of ticker scores this week
The company voluntarily withdrew its US application for accelerated approval of an experimental lung cancer therapy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
20h ago
—
No price for 4568 right now — the quote feed didn't answer.
4568 chart →
